Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 Apr 2020
Historique:
entrez: 19 4 2020
pubmed: 19 4 2020
medline: 19 4 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41467-020-14903-y PMID: 32303677 PMC: PMC7165165
pubmed: 32303677
doi: 10.1038/s41467-020-14903-y
pii: 10.1038/s41467-020-14903-y
pmc: PMC7165165
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1940

Commentaires et corrections

Type : ErratumFor

Auteurs

Ruogu Qi (R)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Yongheng Wang (Y)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Peter M Bruno (PM)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.
ORCID: 0000-0003-3383-0118

Haihua Xiao (H)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Yingjie Yu (Y)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Ting Li (T)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.
Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.

Sam Lauffer (S)

Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.

Wei Wei (W)

Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.

Qixian Chen (Q)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.
ORCID: 0000-0002-3091-671X

Xiang Kang (X)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Haiqin Song (H)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Xi Yang (X)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Xing Huang (X)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Alexandre Detappe (A)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.
Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
ORCID: 0000-0001-9364-1621

Ursula Matulonis (U)

Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.

David Pepin (D)

Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.

Michael T Hemann (MT)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA.

Michael J Birrer (MJ)

Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. mbirrer@mgh.harvard.edu.
Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. mbirrer@mgh.harvard.edu.

P Peter Ghoroghchian (PP)

Koch Institute for Integrative Cancer Research at MIT, 500 Main Street, Cambridge, MA, 02139, USA. ppg@mit.edu.
Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. ppg@mit.edu.
Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA. ppg@mit.edu.

Classifications MeSH